Skellerup reports record first half profit; TruScreen pops on blockbuster China medical trial
Business with Forsyth Barr: Skellerup reports broad-based growth lifting first half NPAT 20% pcp to $28.9m; TruScreen trades heavily on China study validating its screening tool.
